Springhill Fund Asset Management (Hk) CO LTD Nurix Therapeutics, Inc. Transaction History
Springhill Fund Asset Management (Hk) CO LTD
- $61.6 Billion
- Q4 2024
A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 160,500 shares of NRIX stock, worth $2.82 Million. This represents 4.91% of its overall portfolio holdings.
Number of Shares
160,500Holding current value
$2.82 Million% of portfolio
4.91%Shares
1 transactions
Others Institutions Holding NRIX
# of Institutions
179Shares Held
68.2MCall Options Held
304KPut Options Held
43.1K-
Black Rock Inc. New York, NY6.82MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$76.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$73.7 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$68.3 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$63.1 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $829M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...